MIMS Learning Live: South | London, 28th June 2019

Join MIMS Learning in London for our biggest clinical learning event yet!

MIMS Learning Live is a popular event series providing high-quality education for GPs.
MIMS Learning Live is a popular event series providing high-quality education for GPs.

Every GP or nurse attending MIMS Learning Live has in common a love of clinical education that improves the delivery of patient care. With a focus on the practical updates and clinical learning that help you in your day-to-day practice, MIMS Learning Live London in 2019 will be one of the educational highlights of your year. Have a look at the provisional programme to find out more.

Delegates are guaranteed a selection of key clinical learning delivered by engaging expert speakers across six topic streams:

  • Dermatology
  • Diabetes/CVD
  • Women's health
  • Mental health
  • Respiratory
  • Mixed

Further details on stream sessions will be available closer to the event, and delegates will be able to then select their preferred stream.

We accept registrations from UK-based healthcare professionals working in the NHS. We reserve the right to refuse free registration at our discretion – in this event you are welcome to contact our commercial team regarding attendance as a paying delegate. If you have any queries regarding this please contact us at medical@haymarket.com.

Book your place

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

A careful stepwise approach is needed when reducing...

Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome
Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...